CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 200 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,225,296 | +38.3% | 44,965 | +12.9% | 0.00% | – |
| Q2 2023 | $886,240 | -34.7% | 39,831 | -36.4% | 0.00% | -100.0% |
| Q1 2023 | $1,356,436 | +48.0% | 62,624 | +38.8% | 0.00% | 0.0% |
| Q4 2022 | $916,448 | -7.1% | 45,123 | +17.3% | 0.00% | 0.0% |
| Q3 2022 | $986,000 | -13.3% | 38,452 | -19.6% | 0.00% | 0.0% |
| Q2 2022 | $1,137,000 | -12.9% | 47,810 | -17.5% | 0.00% | 0.0% |
| Q1 2022 | $1,305,000 | -3.9% | 57,942 | -15.5% | 0.00% | 0.0% |
| Q4 2021 | $1,358,000 | -81.3% | 68,610 | -81.4% | 0.00% | -66.7% |
| Q3 2021 | $7,279,000 | -15.6% | 369,827 | -5.6% | 0.00% | -25.0% |
| Q2 2021 | $8,622,000 | -2.9% | 391,874 | +5.0% | 0.00% | -20.0% |
| Q1 2021 | $8,878,000 | -17.0% | 373,203 | -8.7% | 0.01% | -28.6% |
| Q4 2020 | $10,690,000 | +20.3% | 408,630 | -20.0% | 0.01% | +16.7% |
| Q3 2020 | $8,889,000 | -40.9% | 510,741 | -42.8% | 0.01% | -45.5% |
| Q2 2020 | $15,030,000 | +43.1% | 893,608 | +1.1% | 0.01% | +22.2% |
| Q1 2020 | $10,505,000 | +1304.4% | 883,545 | +1325.8% | 0.01% | – |
| Q4 2019 | $748,000 | -66.3% | 61,967 | -60.6% | 0.00% | -100.0% |
| Q3 2019 | $2,219,000 | -16.0% | 157,111 | -33.8% | 0.00% | 0.0% |
| Q2 2019 | $2,642,000 | +39.6% | 237,216 | +46.9% | 0.00% | +100.0% |
| Q1 2019 | $1,893,000 | -1.9% | 161,497 | +11.7% | 0.00% | 0.0% |
| Q4 2018 | $1,929,000 | -80.9% | 144,544 | -80.0% | 0.00% | -66.7% |
| Q3 2018 | $10,108,000 | -18.0% | 721,121 | -8.1% | 0.00% | -25.0% |
| Q2 2018 | $12,331,000 | -4.1% | 784,546 | +0.4% | 0.00% | -33.3% |
| Q1 2018 | $12,855,000 | +216.5% | 781,580 | +247.3% | 0.01% | +100.0% |
| Q4 2017 | $4,062,000 | -4.2% | 225,075 | +2.4% | 0.00% | 0.0% |
| Q3 2017 | $4,238,000 | +185.0% | 219,703 | +74.2% | 0.00% | +200.0% |
| Q2 2017 | $1,487,000 | +632.5% | 126,104 | +575.7% | 0.00% | – |
| Q1 2017 | $203,000 | -42.5% | 18,664 | -61.7% | 0.00% | – |
| Q4 2016 | $353,000 | +115.2% | 48,774 | +92.3% | 0.00% | – |
| Q3 2016 | $164,000 | +164.5% | 25,368 | +122.2% | 0.00% | – |
| Q2 2016 | $62,000 | -22.5% | 11,417 | -33.6% | 0.00% | – |
| Q1 2016 | $80,000 | -38.5% | 17,189 | -35.0% | 0.00% | – |
| Q4 2015 | $130,000 | -66.1% | 26,438 | -74.1% | 0.00% | – |
| Q3 2015 | $383,000 | -65.4% | 101,989 | -44.7% | 0.00% | -100.0% |
| Q2 2015 | $1,106,000 | +208.9% | 184,289 | +187.7% | 0.00% | – |
| Q1 2015 | $358,000 | +169.2% | 64,065 | +42.8% | 0.00% | – |
| Q4 2014 | $133,000 | +14.7% | 44,865 | +3.2% | 0.00% | – |
| Q3 2014 | $116,000 | -43.1% | 43,491 | -40.4% | 0.00% | – |
| Q2 2014 | $204,000 | -48.0% | 73,013 | -19.0% | 0.00% | – |
| Q1 2014 | $392,000 | +56.2% | 90,175 | +15.3% | 0.00% | – |
| Q4 2013 | $251,000 | -10.4% | 78,226 | -55.8% | 0.00% | – |
| Q3 2013 | $280,000 | – | 176,967 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |